|
Symbol
|
Z08FFZ | Z08FEZ | Z08FDZ | Z08G8Z | Z08G7Z | Z08G6Z | Z093XZ | Z0972Z | Z0974Z | Z0973Z | Z09FZZ | Z09OXZ | Z24BEZ | Z09QAZ | Z09T9Z | Z09T7Z | Z09T8Z | Z09YGZ | Z09YJZ | Z24BRZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Autocallable Reverse Convertible Defensive worst | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst |
|
Sous-jacent
|
BASF SE / Intel Corp. / Walt Disney Co. | BASF SE / Intel Corp. / Walt Disney Co. | BASF SE / Intel Corp. / Walt Disney Co. | Bayer AG / Biogen Inc. / Henkel AG & Co KGAA (Vz) | Bayer AG / Biogen Inc. / Henkel AG & Co KGAA (Vz) | Bayer AG / Biogen Inc. / Henkel AG & Co KGAA (Vz) | Lonza Group N / Tecan Group AG / Ypsomed Hldg. AG | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | Bristol-Myers Squibb Co. / Pfizer Inc. / Roche GS | ABB N / Companie Financière Richemont SA / Logitech International SA | INFICON Hldg. AG / Kardex AG / Landis+Gyr (Landis Gyr) | Companie Financière Richemont SA / Kering / Swatch Group I | McDonald's Corp. / PepsiCo Inc. / Visa Inc. | 3M Co. / Darling Ingredients Inc. / DuPont de Nemours Inc. | Johnson & Johnson / Nike Inc. / Starbucks Corp. | Akzo Nobel N.V. / BASF SE / Clariant AG | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Galderma Group AG / Sandoz Group AG / VAT Group | Bayerische Motoren Werke AG / Tesla Inc. / Volkswagen AG (Vz) |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
02.11.2026 | 02.11.2026 | 02.11.2026 | 07.05.2026 | 07.05.2026 | 07.05.2026 | 19.02.2026 | 04.03.2026 | 04.03.2026 | 04.03.2026 | 24.04.2026 | 18.12.2025 | 24.12.2025 | 05.01.2026 | 24.07.2026 | 24.07.2026 | 24.07.2026 | 27.08.2027 | 02.03.2026 | 17.09.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
78,1844 | 78,1844 | 78,1844 | 154,401 | 154,401 | 154,401 | 271,20 | 22,9033 | 22,9279 | 22,9033 | 101,3158 | 57,663 | 132,2685 | 125,46 | 23,2313 | 59,908 | 49,2065 | 386,538 | 29,2061 | 35,425 |
| rendement max. p.a. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Demande | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Offre | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |